I thought I was done with immunology. I’m not formally trained as an immunologist, but I fell for it hard back in graduate school, when immunology was leading the molecular biology revolution. Read more.

An Atlas Venture-backed startup that’s developing drugs for various metabolic diseases reached a milestone this week in a partnership that’s totally unrelated to drug discovery — one with the agricultural biotech giant, Monsanto. Read more.

Over the past two weeks in LifeSciVC, I read with great interest and appreciation the blogs of two friends of mine – Bill Marshall and Ankit Mahadevia – as they offered useful perspective on the most powerful tool we have as leaders – company culture.

I am a big believer in working hard at creating the best possible culture for one’s team, so last week, I was deeply honored to see my company recognized as one of the ‘Best Places to Work’ in the state of Pennsylvania.

Read more.

It’s that time of year again: Santa is preparing his list of naughty and nice biotech management teams, and taking his recommendations to the Compensation Committee. Read more.

As startup folks we are great at keeping our heads down and looking ahead; this blog post was a good excuse to take a look back while digesting Thanksgiving leftovers. I’m a bit early for the end of the year analyses; however, in thinking about all of the triumphs and setbacks we’ve encountered in 2014, it occurred to me that much is made of these actual events, but very little is said about how teams handle them.

Read more.